Your browser doesn't support javascript.
loading
Inactivation of the Class II PI3K-C2ß Potentiates Insulin Signaling and Sensitivity.
Alliouachene, Samira; Bilanges, Benoit; Chicanne, Gaëtan; Anderson, Karen E; Pearce, Wayne; Ali, Khaled; Valet, Colin; Posor, York; Low, Pei Ching; Chaussade, Claire; Scudamore, Cheryl L; Salamon, Rachel S; Backer, Jonathan M; Stephens, Len; Hawkins, Phill T; Payrastre, Bernard; Vanhaesebroeck, Bart.
  • Alliouachene S; UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK. Electronic address: s.alliouachene@ucl.ac.uk.
  • Bilanges B; UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.
  • Chicanne G; Inserm/UPS UMR 1048, Institut des Maladies Métaboliques et Cardiovasculaires, 1 Avenue Jean Poulhès BP 84225, 31432 Toulouse Cedex 4, France.
  • Anderson KE; Inositide Laboratory, The Babraham Institute, Cambridge CB22 3AT, UK.
  • Pearce W; UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.
  • Ali K; UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.
  • Valet C; Inserm/UPS UMR 1048, Institut des Maladies Métaboliques et Cardiovasculaires, 1 Avenue Jean Poulhès BP 84225, 31432 Toulouse Cedex 4, France.
  • Posor Y; UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.
  • Low PC; UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.
  • Chaussade C; UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.
  • Scudamore CL; Mary Lyon Centre, MRC Harwell, Harwell Science and Innovation Campus, Harwell OX11 0RD, UK.
  • Salamon RS; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Backer JM; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Stephens L; Inositide Laboratory, The Babraham Institute, Cambridge CB22 3AT, UK.
  • Hawkins PT; Inositide Laboratory, The Babraham Institute, Cambridge CB22 3AT, UK.
  • Payrastre B; Inserm/UPS UMR 1048, Institut des Maladies Métaboliques et Cardiovasculaires, 1 Avenue Jean Poulhès BP 84225, 31432 Toulouse Cedex 4, France.
  • Vanhaesebroeck B; UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK. Electronic address: bart.vanh@ucl.ac.uk.
Cell Rep ; 13(9): 1881-94, 2015 Dec 01.
Article en En | MEDLINE | ID: mdl-26655903
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasas Clase II / Insulina Tipo de estudio: Diagnostic_studies Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasas Clase II / Insulina Tipo de estudio: Diagnostic_studies Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article